Evidence map›Paper›PMID 25926935›Full record

ReviewGastroenterology and hepatology from bed to bench2015

Seronegative celiac disease: where is the specific setting?

Enzo Ierardi, Giuseppe Losurdo, Domenico Piscitelli, Floriana Giorgio, Claudia Sorrentino, Mariabeatrice Principi, Lucia Montenegro, Annacinzia Amoruso, Alfredo Di Leo

Open access · greenAbstract readReview
In one paragraph

Review in Gastroenterology and hepatology from bed to bench, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Non-celiac Enteropathies.Current gastroenterology reports · 2025
    Review
  5. Article
  6. What does not look like celiac disease and instead it is.Gastroenterology and hepatology from bed to bench · 2023
    Article
  7. Article
  8. Celiac Disease Revisited.GE Portuguese journal of gastroenterology · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Dysphagia as a Presentation of Celiac Disease.ACG case reports journal · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Enzo IerardiSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Giuseppe LosurdoSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Domenico PiscitelliSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Floriana GiorgioSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Claudia SorrentinoSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Mariabeatrice PrincipiSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Lucia MontenegroSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Annacinzia AmorusoSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Alfredo Di LeoSection of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of Celiac Disease (CD) relies on the concordance of pathological, serological, genetic and clinical features. For this reason, the diagnosis of CD is often a challenge. Seronegative celiac disease (SNCD) is defined by the negativity of anti-tissue transglutaminase antibodies in the presence of a positive histology on duodenal biopsy samples, i.e. inflammatory infiltrate of intra-epithelial lymphocytes (IELs > 25/100 enterocytes), mild villous atrophy and uneven brush border associated to human leukocyte antigen (HLA) haplotype DQ2 and/or DQ8. SNCD is characterized by mucosal deposits of tissue transglutaminase (tTG)/anti-tTG immuno-complexes. These may counteract the passage of anti-tTG into the bloodstream, thus explaining seronegativity. Another reason for seronegativity may be found in an incomplete maturation of plasma cells with a consequent failure of antibodies production. This condition often characterizes immunoglobulin deficiencies, and, indeed, SNCD is common in subjects with immunoglobulin deficiencies. The management of SNCD still remains debated. The treatment option for SNCD may be represented by gluten free diet (GFD), but the usefulness and appropriateness of prescribing GFD are controversial. Some evidences support its use only in SNCD subjects showing CD clear clinical picture and compatible HLA status. The choice of GFD administration could be linked to an investigation able to diagnose SNCD in no doubt even if a reliable test is not currently available. On these bases, a test helping the diagnosis of SNCD is justifiable and desirable.

Indexed as

DiagnosisImunoglobulinsSerologySeronegative celiac diseaseTissue transglutaminase

Identifiers

PMID25926935
PMCPMC4403023
OpenAlexW1506114106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.